Quantcast
Home > Quotes > GLYC
GLYC

GlycoMimetics, Inc. Common Stock (GLYC) Quote & Summary Data

$12.97
*  
0.13
0.99%
Get GLYC Alerts
*Delayed - data as of Mar. 22, 2019  -  Find a broker to begin trading GLYC now
Exchange:NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Key Stock Data

Best Bid / Ask
N/A / N/A
Today's High / Low
$ 13.24 / $ 12.93
Share Volume
266,878
50 Day Avg. Daily Volume
223,819
Previous Close
$ 13.10
52 Week High / Low
$ 19.20 / $ 8.29
Market Cap
559,901,528
Annualized Dividend
N/A
Ex Dividend Date
N/A
Dividend Payment Date
N/A
Current Yield
0 %

Intraday Chart

Shares Traded

Share Volume:
266,878
50 Day Avg. Daily Volume:
223,819

P/E Ratio

P/E Ratio:
NE
Forward P/E (1y):
NE
Earnings Per Share (EPS):
$ -1.18

Trading Range

The current last sale of $12.97 is 56.45% Higher than the 52 week low.

Intraday Last 52 Weeks
High: $ 13.24 $ 19.20
 Low: $ 12.93 $ 8.29

Company Description (as filed with the SEC)

We are a clinical stage biotechnology company focused on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. Glycomimetics are small molecules that mimic the structure of carbohydrates involved in important biological processes. Using our expertise in carbohydrate chemistry and knowledge of carbohydrate biology, we are developing a pipeline of proprietary glycomimetics designed to inhibit disease-related functions of carbohydrates, such as the roles they play in inflammation, cancer and infection. We believe this represents an innovative approach to drug discovery to treat a wide range of diseases. Our proprietary glycomimetics platform is based on our expertise in carbohydrate chemistry and our understanding of the role carbohydrates play in key biological processes.  ... More ...  



Risk Grade

Where does GLYC fit in the risk graph?


Risk Grade Scale

Nasdaq Official Price

Open Price:
$ 13.02
Open Date:
Mar. 22, 2019
Close Price:
$ 12.97
Close Date:
Mar. 22, 2019


Consensus Recommendation

Analyst Info